StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note released on Wednesday. The brokerage issued a sell rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 4.6 %

TTOO opened at $0.13 on Wednesday. The business’s fifty day simple moving average is $0.16 and its 200 day simple moving average is $0.71. T2 Biosystems has a 52 week low of $0.06 and a 52 week high of $6.80.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.